Biliary strictures complicating living donor liver transplantation: Problems, novel insights and solutions

Table 2 Therapeutic efficacy and factors affecting outcome of endotherapy in biliary strictures complicating living donor liver transplantation

Study	Year	Biliary strictures, n (%)	Median duration of stent therapy	Overall stricture resolution, %	Factors that affected endoscopic outcome
Zoepf et al[68]	2005	7 (7.78)	4 mo	100
Yazumi et al[13]	2006	75 (27.5)	8.9 mo	33
Gomez et al[30]	2009	10 (33.34)		20
Seo et al[43]	2009	29 (12.1)	24.1 ± 12.7 wk	65
Chang et al[22]	2010	113 (32)		48	NAS, HAT, Pretransplant TACE
Hsieh et al[11]	2013	41 (37.3)	5.3 mo	79
Wadhawan et al[93]	2013	35 (10.4)		91
Ranjan et al[94]	2016	10 (3.28)	4 mo	70
Rao et al[31]	2017	41 (10.2)	6 mo	48	Donor age, multiple biliary anastomoses, duration of stent therapy
Kato et al[9]	2009	41 (42.7)	14.5 mo	85	Stricture length, bile leak

HAT: Hepatic artery thrombosis; NAS: Nonanastomotic strictures; TACE: Transarterial chemoembolization.